Keren Yizhak

Technion – Israel Institute of Technology

Also affiliated with Rappaport Family Institute for Research in the Medical Sciences

MedicineNeuroscienceBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Targeting TBK1 to overcome resistance to cancer immunotherapy”.

Targeting TBK1 to overcome resistance to cancer immunotherapy

Nature(2023)10.1038/s41586-023-05704-6

N/A

4.0DataRank · unranked

171 citations

Or‐Yam Revach, Seth Anderson, Emily Kessler, Clara Wolfe, Anne Jenney +54 more

B cells and tertiary lymphoid structures promote immunotherapy response

Nature(2020)10.1038/s41586-019-1922-8

N/A

1.2DataRank · unranked

2564 citations

Sangeetha M. Reddy, Jianjun Gao, Shaojun Zhang, Rafet Başar, Rohit Thakur +55 more

Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq

Science(2017)10.1126/science.aai8478

N/A

1.0DataRank · unranked

1050 citations

Itay Tirosh, Christine Hebert, Keren Yizhak, Cyril Neftel, Mariella G. Filbin +29 more

Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq

Science(2018)10.1126/science.aao4750

N/A

0.989DataRank · unranked

728 citations

Itay Tirosh, Volker Hovestadt, Leah E. Escalante, Nathan D. Mathewson, Cyril Neftel +46 more

Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma

Cell Reports Medicine(2022)10.1016/j.xcrm.2021.100500

N/A

0.972DataRank · unranked

35 citations

Moshe Sade-Feldman, Jaegil Kim, Chip Stewart, Anna Gonye, Arvind Ravi +34 more

Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102210

N/A

0.382DataRank · unranked

9 citations

Angelina M. Cicerchia, Ofir Shorer, Claire A. Palin, Boryana Petrova, Seth Anderson +50 more

Characterizing the tumor and immune landscape of melanoma patients treated with combined checkpoint blockade and MAPK targeted therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.9522

N/A

0.326DataRank · unranked

3 citations

Donald P. Lawrence, David F. McDermott, Mofei Liu, Elizabeth I. Buchbinder, Irena Gushterova +14 more

Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.12.579184

N/A

0.290DataRank · unranked

5 citations

Angelina M. Cicerchia, Ofir Shorer, Boryana Petrova, Seth Anderson, Joshua Park +48 more

Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy

Nature Immunology(2024)10.1038/s41590-024-01792-2

N/A

0DataRank · unranked

132 citations

Linda T. Nieman, Maxwell Spurrell, Vjola Jorgji, Liad Elmelech, Peter Richieri +32 more

Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.03.450733

N/A

0DataRank · unranked

7 citations

Moshe Sade-Feldman, Jaegil Kim, Chip Stewart, Anna Gonye, Arvind Ravi +34 more

Plasma proteomic biomarkers identify non-responders and reveal biological insights about the tumor microenvironment in melanoma patients after PD1 blockade

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.02.478819

N/A

0DataRank · unranked

5 citations

Marijana Ručević, Emmett Sprecher, Milan Parikh, Jiajia Chen, Dennie T. Frederick +23 more